Home・Listă Acțiuni・Anika Therapeutics Inc

Anika Therapeutics Inc

Închisă

SectorSănătate

21.05 1.1

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

20.39

Maxim

21.29

Indicatori cheie
By Trading Economics
Venit	8.4M 3.3M
Vânzări	3M 33M
EPS	0.3
Marjă de profit	10.147
Angajați	235
EBITDA	8.3M 4.9M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+0.77% upside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	87M 286M
Deschiderea anterioară	19.95
Închiderea anterioară	21.05

Sentimentul știrilor

By Acuity

40%

60%

118 / 340 Clasament în Healthcare

Anika Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 aug. 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market hours with no specific news identified for the decline. The stock has gained significantly over the past month.

26 aug. 2026, 21:51 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains, despite no specific company news.

25 aug. 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 aug. 2026, 19:56 UTC

Anika Therapeutics Inc. shares are lower today amid broader market pressures, despite strong performance over the past month and trading above its 20-day moving average.

21 aug. 2026, 21:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, showing unusual strength. No specific news was identified to explain this price movement.

20 aug. 2026, 21:01 UTC

Anika Therapeutics shares are trading higher in after-market hours, showing steady gains since Thursday's close and remaining above the 20-day moving average.

19 aug. 2026, 22:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading. No specific news was identified to explain the decline following Wednesday's close.

18 aug. 2026, 20:06 UTC

Anika Therapeutics Inc's shares are higher during Tuesday's session, reflecting overall positive market performance, despite pulling back slightly from an earlier peak.

17 aug. 2026, 20:06 UTC

Anika Therapeutics Inc shares are lower amid broader market declines, reflecting significant downward pressure following disappointing U.S. retail sales data for July.

14 aug. 2026, 22:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

13 aug. 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 aug. 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 aug. 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 aug. 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 aug. 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 aug. 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 aug. 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 aug. 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 aug. 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 iul. 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30 iul. 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29 iul. 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28 iul. 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27 iul. 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24 iul. 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22 iul. 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21 iul. 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20 iul. 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Comparație

Modificare preț

Anika Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

0.77% sus

Prognoză pe 12 luni

Medie 21 USD 0.77%

Maxim 21 USD

Minim 21 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAnika Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Anika Therapeutics Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

118 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.